Assistant Research Fellow, Ngāi Tahu Māori Health Research Unit, University of Otago, Dunedin, Aotearoa New Zealand.
Programme Manager, Te Whatu Ora Waitematā, Auckland, Aotearoa New Zealand.
N Z Med J. 2024 Apr 12;137(1593):45-55. doi: 10.26635/6965.6335.
Lung cancer causes more deaths than any other cancer, globally and in Aotearoa New Zealand, where it disproportionately affects Māori. We aimed to understand Māori perspectives on lung cancer screening in Aotearoa New Zealand to guide its equity-focussed implementation, including identifying enablers and barriers.
We took a Kaupapa Māori based co-design approach to inform future screening, recruiting Māori current/ex-smokers and members of their whānau (family) for three focus group phases held in Auckland, Aotearoa New Zealand in August 2019. Participants responded to a proposed lung cancer screening pathway and shared their attitudes and beliefs about lung cancer and screening. Results were thematically analysed.
The 21 Māori participants supported future lung cancer screening in Aotearoa New Zealand. Perceived benefits included being more informed about lung cancer and screening and enabling healthier future generations. Barriers to screening were previous negative health service experiences; fear; stigma; and access, including time, cost and transport. Enablers included providers' cultural competence; clear communication; a one-stop shop; and support with transport. A range of factors could potentially influence a decision to participate in screening.
Participants favoured future lung cancer screening and identified key barriers and facilitators of screening.
肺癌是全球和新西兰（在该国，毛利人受到的影响尤为严重）导致死亡人数最多的癌症。我们旨在了解毛利人对新西兰肺癌筛查的看法，以指导其公平实施，包括确定促进因素和障碍。
我们采用基于毛利人观点的共同设计方法来为未来的筛查提供信息，招募了毛利族当前/曾经的吸烟者及其家庭成员参加 2019 年 8 月在新西兰奥克兰举行的三个焦点小组阶段。参与者对拟议的肺癌筛查途径做出了回应，并分享了他们对肺癌和筛查的态度和信念。结果进行了主题分析。
21 名毛利参与者支持在新西兰未来进行肺癌筛查。认为的益处包括更了解肺癌和筛查，以及使后代更健康。筛查的障碍包括以前的负面卫生服务体验；恐惧；污名化；以及获取筛查的机会，包括时间、费用和交通。促进因素包括提供者的文化能力；清晰的沟通；一站式服务；以及交通支持。一系列因素可能会影响参与筛查的决定。
参与者赞成未来进行肺癌筛查，并确定了筛查的主要障碍和促进因素。
